GB2217602A - Treatment of inflammatory disorders in humans - Google Patents

Treatment of inflammatory disorders in humans Download PDF

Info

Publication number
GB2217602A
GB2217602A GB8908831A GB8908831A GB2217602A GB 2217602 A GB2217602 A GB 2217602A GB 8908831 A GB8908831 A GB 8908831A GB 8908831 A GB8908831 A GB 8908831A GB 2217602 A GB2217602 A GB 2217602A
Authority
GB
United Kingdom
Prior art keywords
acid
fatty acids
inflammatory
effective amount
cyclic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GB8908831A
Other languages
English (en)
Other versions
GB8908831D0 (en
Inventor
Michael Wellesley Whitehouse
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medvet Science Pty Ltd
Original Assignee
Medvet Science Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medvet Science Pty Ltd filed Critical Medvet Science Pty Ltd
Publication of GB8908831D0 publication Critical patent/GB8908831D0/en
Publication of GB2217602A publication Critical patent/GB2217602A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB8908831A 1988-04-22 1989-04-19 Treatment of inflammatory disorders in humans Withdrawn GB2217602A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPI786888 1988-04-22

Publications (2)

Publication Number Publication Date
GB8908831D0 GB8908831D0 (en) 1989-06-07
GB2217602A true GB2217602A (en) 1989-11-01

Family

ID=3773040

Family Applications (1)

Application Number Title Priority Date Filing Date
GB8908831A Withdrawn GB2217602A (en) 1988-04-22 1989-04-19 Treatment of inflammatory disorders in humans

Country Status (5)

Country Link
AU (1) AU616502B2 (de)
DE (1) DE3913194A1 (de)
FR (1) FR2630648A1 (de)
GB (1) GB2217602A (de)
NZ (1) NZ228862A (de)

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0454429A2 (de) * 1990-04-27 1991-10-30 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Verwendung von 15-Dehydroxy-16-Oxoprostaglandin bei der Behandlung von allergischen Erkrankungen
EP0467564A2 (de) * 1990-07-10 1992-01-22 R-Tech Ueno Ltd. Behandlung von entzündlichen Erkrankungen mit 15-Ketoprostaglandinen
US5302617A (en) * 1990-04-27 1994-04-12 Kabushikikaisha Ueno Seiyaku Oyo Kenkyuio Biochemical treatment with 15-dehydroxy-16-oxoprostaglandin compounds
WO1995013806A1 (en) * 1993-11-18 1995-05-26 Kappa Pharmaceuticals Limited Compositions containing zinc linoleate for the treatment of skin disorders
FR2740335A1 (fr) * 1995-10-26 1997-04-30 Oreal Utilisation de sel de lanthanide, de lithium, d'etain, de zinc, de manganese ou d'yttrium comme antagoniste de substance p
WO1999003463A1 (en) * 1997-07-18 1999-01-28 Kelly Patrick D Genital lubricants with zinc to reduce irritation and allergic reactions
US5980477A (en) * 1991-07-29 1999-11-09 Patrick Kelly Genital lubricants with zinc salts as anti-viral additives
EP1166788A1 (de) * 1999-03-10 2002-01-02 Takata Seiyaku Kabushiki Kaisha Arzneimittel für gelenkkrankheiten
US6423325B1 (en) 1999-07-30 2002-07-23 Conopco, Inc. Skin care composition
CN1133786C (zh) * 1994-11-08 2004-01-07 乌尔里克·赫德尔梅尔 泵送混凝土用的装置
WO2007066232A2 (en) * 2005-10-07 2007-06-14 Ocean Nutrition Canada Ltd. Salts of fatty acids and methods of making and using thereof
US8552064B2 (en) 2002-03-26 2013-10-08 Eastern Virginia Medical School Suramin and derivatives thereof as topical microbicide and contraceptive
WO2019219093A3 (zh) * 2018-05-15 2019-12-19 南京医科大学 亚麻酸锌的制备及其在制备抗幽门螺杆菌药物中的应用

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4022815A1 (de) * 1990-07-18 1992-01-23 Braun Melsungen Ag Topische verwendung von (omega)-3-fettsaeuren-zubereitungen fuer hauterkrankungen
DE4042437A1 (de) * 1990-07-18 1992-06-11 Braun Melsungen Ag Topische verwendung von (omega)-3-fettsaeuren-zubereitungen fuer verbrennungen
EP0806207A4 (de) * 1995-01-18 2002-01-02 Taisho Pharmaceutical Co Ltd Heilmittel für ekzeem
FR2873295B1 (fr) * 2004-07-26 2006-12-01 Expanscience Sa Lab Utilisation d'au moins un triene d'acide gras conjugue pour la preparation d'un medicament destine au traitement de l'inflammation

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB798655A (en) * 1956-03-15 1958-07-23 Biorex Laboratories Ltd Improvements in or relating to therapeutic compositions
GB2029441A (en) * 1978-08-21 1980-03-19 Toyo Aerosol Ind Co Powder aerosol composition
US4309415A (en) * 1978-04-11 1982-01-05 Verronmay Limited Method and composition for treating inflammatory disorders
US4444755A (en) * 1978-01-23 1984-04-24 Efamol Limited Treatment for skin disorders

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB943282A (en) * 1960-10-13 1963-12-04 Peter James Shannon Hair restorer
FR2406775A1 (fr) * 1977-10-19 1979-05-18 Fmc Europe Dispositif de couplage a deconnexion rapide pour applications cryogeniques
US4273763A (en) * 1978-01-23 1981-06-16 Efamol Limited Pharmaceutical and dietary compositions
IE47777B1 (en) * 1978-01-23 1984-06-13 Efamol Ltd Pharmaceutical and dietary composition comprising gamma-linolenic acids
WO1982001867A1 (en) * 1980-11-24 1982-06-10 Alan J Brock Pharmaceutical compound and method
AU556817B2 (en) * 1982-02-03 1986-11-20 Efamol Limited Topical application of a lithium salt and dihomo-alpha- linolenic acid
FR2548021B1 (fr) * 1983-06-29 1986-02-28 Dick P R Compositions pharmaceutiques dermiques a action prolongee et continue a base d'acides gras essentiels
WO1986000251A1 (en) * 1984-06-22 1986-01-16 The Taylor-Winfield Corporation Robot welder
US4621075A (en) * 1984-11-28 1986-11-04 The Procter & Gamble Company Gel-form topical antibiotic compositions
WO1987001281A1 (en) * 1985-08-27 1987-03-12 Glyzinc Pharmaceuticals Limited Zinc glycerolate complex and additions for pharmaceutical applications

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB798655A (en) * 1956-03-15 1958-07-23 Biorex Laboratories Ltd Improvements in or relating to therapeutic compositions
US4444755A (en) * 1978-01-23 1984-04-24 Efamol Limited Treatment for skin disorders
US4309415A (en) * 1978-04-11 1982-01-05 Verronmay Limited Method and composition for treating inflammatory disorders
GB2029441A (en) * 1978-08-21 1980-03-19 Toyo Aerosol Ind Co Powder aerosol composition

Cited By (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0454429A3 (en) * 1990-04-27 1992-07-15 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Use of 15-dehydroxy-16-oxoprostaglandin derivatives in the treatment of allergic diseases
US5302617A (en) * 1990-04-27 1994-04-12 Kabushikikaisha Ueno Seiyaku Oyo Kenkyuio Biochemical treatment with 15-dehydroxy-16-oxoprostaglandin compounds
EP0454429A2 (de) * 1990-04-27 1991-10-30 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Verwendung von 15-Dehydroxy-16-Oxoprostaglandin bei der Behandlung von allergischen Erkrankungen
EP0467564A2 (de) * 1990-07-10 1992-01-22 R-Tech Ueno Ltd. Behandlung von entzündlichen Erkrankungen mit 15-Ketoprostaglandinen
EP0467564A3 (en) * 1990-07-10 1992-07-08 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Treatment of inflammatory diseases with 15-keto-prostaglandin compounds
US5346921A (en) * 1990-07-10 1994-09-13 R-Tech Ueno, Ltd. Treatment of inflammation with 15-keto-prostaglandin compounds
US5980477A (en) * 1991-07-29 1999-11-09 Patrick Kelly Genital lubricants with zinc salts as anti-viral additives
US5792449A (en) * 1993-11-18 1998-08-11 Kappa Pharmaceuticals Limited Compositions containing zinc linoleate for the treatment of skin disorders
WO1995013806A1 (en) * 1993-11-18 1995-05-26 Kappa Pharmaceuticals Limited Compositions containing zinc linoleate for the treatment of skin disorders
CN1133786C (zh) * 1994-11-08 2004-01-07 乌尔里克·赫德尔梅尔 泵送混凝土用的装置
FR2740335A1 (fr) * 1995-10-26 1997-04-30 Oreal Utilisation de sel de lanthanide, de lithium, d'etain, de zinc, de manganese ou d'yttrium comme antagoniste de substance p
US5900257A (en) * 1995-10-26 1999-05-04 Societe L'oreal S.A. Cosmetic/pharmaceutical compositions comprising lanthanide manganese, tin and/or yttrium salts as substance P antagonists
EP0770392A3 (de) * 1995-10-26 1997-05-07 L'oreal Verwendung von Lanthanide-, Zinn-, Mangan-, Yttrium-, Kobalt-, Barium-, Strontiumsalzen in einer pharmazeutische Zusammensetzung
WO1999003463A1 (en) * 1997-07-18 1999-01-28 Kelly Patrick D Genital lubricants with zinc to reduce irritation and allergic reactions
CZ301736B6 (cs) * 1999-03-10 2010-06-09 Takata Seiyaku Co., Ltd. Prostredek pro lécbu arthritidy
EP1166788A4 (de) * 1999-03-10 2007-10-10 Takata Seiyaku Kabushiki Kaish Arzneimittel für gelenkkrankheiten
EP1166788A1 (de) * 1999-03-10 2002-01-02 Takata Seiyaku Kabushiki Kaisha Arzneimittel für gelenkkrankheiten
US6423325B1 (en) 1999-07-30 2002-07-23 Conopco, Inc. Skin care composition
US8552064B2 (en) 2002-03-26 2013-10-08 Eastern Virginia Medical School Suramin and derivatives thereof as topical microbicide and contraceptive
WO2007066232A2 (en) * 2005-10-07 2007-06-14 Ocean Nutrition Canada Ltd. Salts of fatty acids and methods of making and using thereof
WO2007066232A3 (en) * 2005-10-07 2007-11-01 Ocean Nutrition Canada Ltd Salts of fatty acids and methods of making and using thereof
WO2019219093A3 (zh) * 2018-05-15 2019-12-19 南京医科大学 亚麻酸锌的制备及其在制备抗幽门螺杆菌药物中的应用
US11203563B2 (en) 2018-05-15 2021-12-21 Nanjing Medical University Preparation of zinc linolenate, and application of zinc linolenate in preparing anti-helicobacter pylori drug

Also Published As

Publication number Publication date
FR2630648A1 (de) 1989-11-03
DE3913194A1 (de) 1989-11-02
AU616502B2 (en) 1991-10-31
NZ228862A (en) 1991-03-26
AU3300689A (en) 1989-10-26
GB8908831D0 (en) 1989-06-07

Similar Documents

Publication Publication Date Title
AU616502B2 (en) Treatment of inflammatory disorders in humans
AU740443B2 (en) Fatty acid uninterrupted by a methylene as anti-inflammatory agents in superficial tissues of mammals
RO108220B1 (ro) Preparate farmaceutice,pentru combaterea carceilor musculari si procedeu de obtinere a acestora
JP2009526033A (ja) オメガ３
AU1177595A (en) Butyric ester cyto-differentiating agents
CA2325887A1 (fr) Procede d'obtention d'une huile enrichie en acides gras hydroxyoctadecadienoiques (hode) ou de ses esters, a partir d'un melange huileux contenant de l'acide linoleique, ou ses esters
EP0183322A2 (de) Gelförmige antibiotische Mittel zur äusserlichen Anwendung
GB2202145A (en) Topical pharmaceutical compositions
KR950013763B1 (ko) 레티노산 글루쿠로나이드를 포함하는 약제학적 조성물
US6376498B1 (en) Pharmaceutical, cosmetic and/or food composition with antioxidant properties
CN114126581A (zh) 包含十六烷化脂肪酸的组合物及其用于治疗关节炎和关节炎症的用途
JPH05331050A (ja) 消炎鎮痛外用剤
EP0354848A1 (de) Pharmazeutische und/oder diätetische Zusammensetzungen mit Gehalt an L-Carnitin und L-Lysin
JP3215133B2 (ja) 消炎鎮痛外用剤
JP3231079B2 (ja) 消炎鎮痛外用剤
EP0429856B1 (de) Neue Arzneizubereitungen, ein Metallsalz des Ibuprofens enthaltend und Verfahren zur Herstellung derselben
JP3208719B2 (ja) 消炎鎮痛外用剤
FR2649322A1 (fr) Complexes biodisponibles d'acide (alpha)-linolenique, extraits de plantes en contenant et compositions pharmaceutiques les incorporant
US20220220414A1 (en) Method for preparing a composition comprising cetylated fatty acids
PL200231B1 (pl) Środek farmaceutyczny i/lub kosmetyczny zawierający kwas pantotenowy i/lub jego pochodne oraz zastosowanie mieszaniny kwasu pantotenowego i/lub jego pochodnych
WO2020240441A1 (en) Compositions comprising cetylated fatty acids for use in the treatment of gastric mucosa, diabetes and high blood glucose levels
JP3153596B2 (ja) 消炎鎮痛外用剤
EA045244B1 (ru) Способ приготовления композиции, содержащей цетилированные жирные кислоты
FR2594334A1 (fr) Composition pharmaceutique injectable a base d'amoxicilline
JPH0220612B2 (de)

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)